Yes, procedures for treating Fuchs endothelial dystrophy are corneal graft surgeries.
All surgical treatments for Fuchs endothelial dystrophy involve transplantation of donor corneal tissue (grafts), making them definitively graft surgeries. 1
Types of Corneal Graft Surgeries for Fuchs Dystrophy
The evidence clearly demonstrates that 95% of Fuchs dystrophy patients are treated with endothelial keratoplasty (EK), which encompasses several graft-based techniques 1:
Primary Graft Procedures:
DMEK (Descemet's Membrane Endothelial Keratoplasty): Replaces diseased Descemet's membrane/endothelium with healthy donor Descemet's membrane/endothelium 1
DSAEK/DSEK (Descemet's Stripping Automated/Endothelial Keratoplasty): Replaces recipient Descemet's membrane with a thin donor lenticule that includes posterior stroma and Descemet's membrane 1
PK (Penetrating Keratoplasty): Full-thickness corneal graft replacement 1
DLEK (Deep Lamellar Endothelial Keratoplasty): Removes and replaces posterior stromal/Descemet's membrane lenticule with donor tissue 1
Key Evidence Supporting Graft Nature
The guideline explicitly refers to these procedures using terminology that confirms their graft status 1:
- "Graft decentration or dislocation"
- "Graft rejection" rates (ranging from 0-22% depending on technique)
- "Graft failure rate at 5 years"
- "Donor tissue preparation"
- "Donor lenticule"
- Eye Bank Association data tracking "keratoplasties" (graft surgeries)
All these procedures require donor corneal tissue from eye banks and carry risks inherent to transplantation, including graft rejection, graft failure, and the need for immunosuppression in some cases 1.
The only potential exception mentioned is experimental Descemet membrane transplantation (DMT) using acellular tissue, but this remains investigational 2.